October 05th, 2023

AirSculpt Technologies, Inc. (Nasdaq: AIRS), a medical technology company specializing in body contouring procedures, has provided a positive outlook for its third-quarter 2023 revenue, with expectations set at approximately $46.5 million, surpassing. Read more

October 04th, 2023

Cambium Networks Corporation (Nasdaq: CMBM), a technology company, has adjusted its third-quarter 2023 revenue expectations to between $40.0 million and $45.0 million, a substantial shift from the previous outlook of $62.0 million to $70.0 million. T. Read more

October 04th, 2023

Shares of Vivos Therapeutics, Inc. (Nasdaq: VVOS) surged by more than 40% in pre-market trading following the announcement of strategic agreements with Ormco and On Demand Orthodontist. These agreements pave the way for Spark Clear Aligners to be off. Read more

October 04th, 2023

Acuity Brands, Inc. (NYSE: AYI) posted fourth-quarter fiscal 2023 earnings of $3.97 per share, surpassing the consensus EPS estimate of $3.72. Quarterly sales for the company totaled $1.01 billion, slightly below analysts' revenue projections of $1.0. Read more

October 04th, 2023

UBS upgraded Fluor Corporation (NYSE: FLR), a leading engineering and construction company, from Neutral to Buy and raised the price target from $35 to $47 With $FLR closing at $34.62 on Tuesday, the new price target implies a potential upside of . Read more

October 03rd, 2023

Shares of Brooge Energy Ltd. (Nasdaq: BROG) surged by more than 20% in after-hours trading as Gulf Navigation Holdings PJSC (GULFNAV), a Dubai-based maritime and shipping company, submitted a formal proposal to fully acquire all of Brooge Energy Limi. Read more

October 03rd, 2023

Shares of ALX Oncology Holdings Inc. (Nasdaq: ALXO) surged by more than 100% in pre-market trading after the company unveiled positive interim Phase 2 data from the ASPEN-06 clinical trial evaluating its CD47 blocking therapeutic evorpacept in combin. Read more

October 03rd, 2023

Shares of ALX Oncology Holdings Inc. (Nasdaq: ALXO) surged by more than 20% in after-hours trading following the announcement that it will unveil interim Phase 2 ASPEN-06 clinical trial results of evorpacept, aimed at treating advanced HER2-positive . Read more

October 02nd, 2023

Lockheed Martin Rotary and Mission Systems, a business segment of Lockheed Martin Corporation (NYSE: LMT), has been granted a $10,854,384 cost-plus-fixed-fee modification to a previously awarded contract for Extra Large Unmanned Undersea Vehicle engi. Read more

October 02nd, 2023

Shares of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) surged by more than 20% in pre-market trading following the company's decision to discontinue its Phase 2b clinical trial of ibezapolstat, its lead antibiotic candidate, designed for the treatment . Read more